Based on the results of this study, GHESKIO opened an adolescent HIV clinic with the support of the United Nations Children's Fund to provide primary-care services, nutritional support, and ...

ZANZIBAR: AS the world commemorates the International Day against Drug Abuse and Illicit Trafficking each year on June 26, ...

Last year, an HHS panel released recommendations for the use of statin therapy as primary prevention of atherosclerotic cardiovascular disease (ASCVD) in people with HIV. Researchers are ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

“What could be an extraordinary game changer for HIV prevention is being completely undermined by Gilead’s greed. Charging $28,218 a year will drastically limit the availability of the drug.

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months. The new drug, lenacapavir ...

Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in ...

That's a less frequent dosage than for all existing HIV prevention medications, including daily pills from Gilead and another injection, from GSK, taken every other month.

That makes Yeztugo a valuable and far more convenient tool for addressing an epidemic that led to around 1.3 million new infections and contributed to the deaths of 630,000 people globally in 2023 ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa ...

WASHINGTON — A newly approved HIV prevention drug that requires just two doses a year is generating excitement among health professionals in Colorado and across the U.S., who hope it will help ...